Search alternatives:
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
63921
N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh<sub>3</sub> and IPr
Published 2012“…Rh and Au complexesRhCl(<b>2a</b>)(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl(<b>2b</b>)(cod) (<b>3b</b>), RhCl(<b>2a</b>)(CO)<sub>2</sub> (<b>4a</b>), RhCl(<b>2b</b>)(CO)<sub>2</sub> (<b>4b</b>), and AuCl(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”
-
63922
Table_1_Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study.DOCX
Published 2022“…There was a trend toward decreasing CSI and DFA α1 and increasing CVI in the first 8 months of age.…”
-
63923
N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh<sub>3</sub> and IPr
Published 2012“…Rh and Au complexesRhCl(<b>2a</b>)(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl(<b>2b</b>)(cod) (<b>3b</b>), RhCl(<b>2a</b>)(CO)<sub>2</sub> (<b>4a</b>), RhCl(<b>2b</b>)(CO)<sub>2</sub> (<b>4b</b>), and AuCl(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”
-
63924
N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh<sub>3</sub> and IPr
Published 2012“…Rh and Au complexesRhCl(<b>2a</b>)(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl(<b>2b</b>)(cod) (<b>3b</b>), RhCl(<b>2a</b>)(CO)<sub>2</sub> (<b>4a</b>), RhCl(<b>2b</b>)(CO)<sub>2</sub> (<b>4b</b>), and AuCl(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”
-
63925
-
63926
DataSheet_1_Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review.pdf
Published 2021“…Hyperthyroidism (OR 3.8, 95%CI 1.7–8.6), nausea (OR 3.7, 95%CI 2.5–5.3), diarrhea (OR 2.7, 95%CI 2.2–3.2), colitis (OR 3.4, 95%CI 2.7–4.3), ALT increase (OR 4.9, 95%CI 3.9–6.1), AST increase (OR 3.8, 95%CI 3.0–4.9), pruritus (OR 2.4, 95%CI 1.5–3.9), rash (OR 2.8, 95%CI 2.1–3.8), fatigue (OR 2.8, 95%CI 2.2–3.7), decreased appetite (OR 2.4, 95%CI 1.5–3.8), and hypophysitis (OR 2.0, 95%CI 1.2–3.3) were more frequent with combined ICIs. …”
-
63927
New Conclusions Regarding Comparison of Sevelamer and Calcium-Based Phosphate Binders in Coronary-Artery Calcification for Dialysis Patients: A Meta-Analysis of Randomized Controll...
Published 2015“…An analysis pooling showed a significant decrease in serum levels of phosphate with calcium-based phosphate binders (CBPBs) by 0.17 mg/dL [mean difference (MD), 95% CI, 0.03, 0.31] than sevelamer. …”
-
63928
-
63929
-
63930
-
63931
-
63932
-
63933
-
63934
-
63935
-
63936
-
63937
-
63938
-
63939
-
63940